NCT02715583View on ClinicalTrials.gov

C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 25, 2020

Study Completion Date

September 25, 2020

Conditions
Prostate Cancer Patients
Interventions
DRUG

11C-Acetate

Trial Locations (1)

19004

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02715583 - C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer | Biotech Hunter | Biotech Hunter